Wednesday, August 15, 2018

Vladimir Zah

Visiting Professor, Kozminski University, CEO at ZRx Outcomes Research Inc

Vladimir Zah
Vladimir Zah

Vladimir Zah, PhD(c), brings 20+ years of Health Economics technology and business experience. Since 2000, in various roles as Health Economist, Project Manager and Chief Investigator, Vlad has implemented more than 170 health economic models and assessments in the phase 2, 3 and 4 settings, across various disease areas for top 20 global pharmaceutical companies; work supported with over 50 publications.

His PhD research on early vs. late HIV detection in the United Kingdom contributed to revisions in HIV early detection policies made by the UK Parliament in 2011.

Since 2010, he has been data-mining large public and private payer US healthcare datasets, which resulted in over 20 publications.

Vlad resides as an active member on various ISPOR (International Society for Pharmacoeconomics and Outcomes Research) bodies. Since 2017, he is a current member of ISPOR Health Science Policy Council (research area), the highest scientific body in HEOR community. Since 2016, Vlad is the Global Meeting Travel Grant Committee Chair. He is also past CEE (Central East Europe) Executive Committee Chair 2015-17, with 26 country chairs directly reporting to him. During his tenure, he successfully initiated conversion of ISPOR CEE Network to ISPOR CEE Consortium and implemented first multi-criteria decision making (MCDA) cross border studies in the area of Oncology and Rare Diseases.

Vlad lectures extensively and serves as a key opinion leader in the areas of HEOR, MCDA, opioid addiction, HIV, diabetes and other. He also consults and provided HEOR training relating to both medications and medical devices to Ministry of Health, National Insurance Funds or at national congresses in Russia, Turkey, Greece, Egypt, Poland, Czech Republic, Slovakia, Hungary, Croatia, Bosnia & Herzegovina, Slovenia, FYROM, Republic of Srpska and India..

International Speakers

Michael Drummond Mike Drummond is Professor of Health Economics and was Director of the Centre from December 1995 to September 2005. His particular field of interest is in the economic evaluation of health care treatments and programmes.
Dr Panos Kanavos Panos Kanavos (BSc, MSc (Oxon), MSc (LSE), PhD) is Reader in International Health Policy in the Department of Social Policy, London School of Economics (LSE) and Programme Director of the Medical Technology Research Group (MTRG) at LSE Health.
Katarzyna Kolasa, PhD Katarzyna Kolasa has more than 16 years of working experience in the healthcare sector, with 10 years with the pharmaceutical and medical devices industry and six with the public payer.
Vladimir Zah Vladimir Zah, PhD(c), brings 20+ years of Health Economics technology and business experience. Since 2000, in various roles as Health Economist, Project Manager and Chief Investigator, Vlad has implemented more than 170 health economic models and assessments in the phase 2, 3 and 4 settings, across various disease areas for top 20 global pharmaceutical companies; work supported with over 50 publications.
  • ORGANIZED BY
  • IN COOPERATION WITH
  • SPONSOR
  • SUPPORTERS
  • MEDIA PARTNER
  • MEDIA SPONSORS
  • CONFERENCE EXPERIENCE SPONSOR

© 2018 Boussias Communications, all rights reserved. info@boussias.com, T:210 6617777, F:210 6617778

Designed by Boussias
New Media Team